Domperidone for Refractory Gastrointestinal Disorders
Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prescribe oral domperidone for subjects with gastrointestinal
disorders who have failed or suffered adverse effects from standard medical treatment.